Our study revealed increased levels of IGF-1 in BE and EAC obese tissues, increased expression of Ki-67 (a marker of cell proliferation) in BE and EAC tissues, and decreased proliferation and migration of EAC cells with IGF1 inhibition. The gene discussed is MKI67; the disease is Barrett esophagus.